Vaccine News and Research

Latest Vaccine News and Research

Immediate action needed to curb spread of TB, especially among children

In this post in the Huffington Posts "Impact" blog, Kolleen Bouchane, director of ACTION, an international partnership of advocates working to mobilize resources to treat and prevent the spread of tuberculosis (TB), examines the need for improved TB vaccines and diagnostics in order to curb the spread of multidrug-resistant TB, especially among children, and highlights ACTION's new report.

27 Sep 2011

HIV vaccine research showing promise

Recent findings on HIV vaccine research, some presented recently at the AIDS Vaccine 2011 conference in Bangkok, "show that the science of an AIDS vaccine is vibrant and vital," Mitchell Warren, executive director of AVAC-Global Advocacy for HIV Prevention, writes in a "Science Speaks" guest blog post.

27 Sep 2011

Rush Foundation, Copenhagen Consensus Center examine how to spend hypothetical AIDS funding

In this post in the Center for Global Developments "Global Health Policy" blog, Mead Over, a senior fellow at the center, writes that the Rush Foundation has asked the Copenhagen Consensus Centre to address the question of how to spend an additional, but hypothetical, $10 billion on HIV/AIDS programs in Africa over the next five years.

27 Sep 2011

Researchers modify HIV in a way that makes it no longer able to suppress immune system

Researchers at Johns Hopkins have modified HIV in a way that makes it no longer able to suppress the immune system. Their work, they say in a report published online September 19 in the journal Blood, could remove a major hurdle in HIV vaccine development and lead to new treatments.

27 Sep 2011

University of Zurich receives AICR grant to improve vaccines against Burkitt's lymphoma

Research in Switzerland could help reduce the time taken to develop vaccines against cancer tumours.

27 Sep 2011

MSU creates new malaria vaccine with immune-stimulating gene

Continuing a global effort to prevent malaria infections, Michigan State University researchers have created a new malaria vaccine - one that combines the use of a disabled cold virus with an immune system-stimulating gene - that appears to increase the immune response against the parasite that causes the deadly disease.

27 Sep 2011

Roundup: Patient dies after medical error during Calif. nurses strike; grocery workers ratify contract that had partially hinged on health care

Veteran nurses locked out of Alta Bates Summit Medical Center in Oakland said Sunday that the death of a patient due to a medical error by a replacement worker wouldn't have happened if they had been allowed to do their jobs. The hospital's management countered that it was a freak accident that could have happened at any time -- with or without the replacement nurses. At the center of the dispute is a cancer patient, a woman who has not been identified but whose tragic death on Saturday has inflamed an already tense labor dispute.

27 Sep 2011

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

An international collaboration between Vaxent, a Memphis-based early stage vaccine development company in the Memphis Bioworks Foundation Incubator, and The Pan-Provincial Vaccine Enterprise Inc. (PREVENT), a Centre of Excellence for Commercialization and Research (CECR) in Saskatchewan, has put a vaccine for group A streptococcus (Strep-A) back on the path for potential commercialization.

26 Sep 2011

Afinitor Phase III study on angiomyolipomas associated with TSC meets primary endpoint

A Phase III study of Afinitor (everolimus) tablets in patients with non-cancerous kidney tumors, or angiomyolipomas, associated with tuberous sclerosis complex (TSC) met its primary endpoint of best overall angiomyolipoma response rate, which includes reduction in kidney tumor size and absence of new tumors.

26 Sep 2011

Combination of Afinitor, exemestane reduces risk of breast cancer progression in women

A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.

26 Sep 2011

Fact check: Health care claims in Republican debate

News organizations have been looking into candidates' statements from Thursday night's debate, including one by Gov. Rick Perry about Mitt Romney's book, Rep. Michele Bachmann and Perry on the HPV vaccine and Herman Cain on his cancer and the health law.

26 Sep 2011

Britain’s health workers urged to get flu shots to protect patients

Britain’s National Health Service (NHS) is urging its staff to take their flu shots amid fresh warnings that low vaccination rates among health professionals could lead to vulnerable patients getting infected and dying. The NHS's employers, health trade unions and the Department of Health have launched a campaign to tackle low immunization rates among frontline staff such as doctors and nurses.

26 Sep 2011

Rotavirus vaccine saved 65,000 hospitalizations and $278 million in healthcare costs: Study

The latest research shows that since the 2006 introduction of routine inoculation against rotavirus -- a leading cause of diarrhea in infants and young children -- almost 65,000 fewer American children have been hospitalized and about $278 million in healthcare costs have been saved.

26 Sep 2011

Janssen Biotech receives FDA approval for Remicade to treat UC in children

The U.S. Food and Drug Administration today approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.

26 Sep 2011

Vaccination must be part of response to cholera outbreak in Haiti

Though "[c]holera vaccines are not a magic bullet and are not available in adequate numbers" to vaccinate everyone in Haiti, where at least 10 people die each day in an outbreak that began in October 2010, "there are compelling reasons to add vaccinations to the arsenal of public health weapons that has been deployed against cholera in Haiti," a Washington Post editorial states.

23 Sep 2011

EMA CHMP adopts positive opinion for Soliris to treat atypical hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. today announced that the European Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that the therapeutic indication for Soliris® (eculizumab) be extended to include the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS) in Europe.

23 Sep 2011

Is enough being done to fight child mortality?

Though the recent UNICEF report on child mortality shows progress is being made in every region to prevent childhood deaths, "it is clear that we still need to increase the coverage of high-impact, low-cost interventions like vaccines, including those for pneumonia and diarrhea that are rolling out," Melinda Gates, co-chair of the Bill & Melinda Gates Foundation.

23 Sep 2011

Bachmann, Perry wrestle over HPV issue

During the last debate, Michele Bachmann and Rick Perry clashed over their positions on the HPV vaccine. During Thursday night's Orlando debate, the issue again emerged.

23 Sep 2011

First Edition: September 23, 2011

In today's headlines, the skinny on how health policy issues played in Thursday night's GOP presidential primary debate.

23 Sep 2011

Study identifies genetic mutations that affect immune response to measles vaccination

Researchers at Mayo Clinic are hacking the genetic code that controls the human response to disease vaccination, and they are using this new cipher to answer many of the deep-seated questions that plague vaccinology, including why patients respond so differently to identical vaccines and how to minimize the side effects to vaccination.

23 Sep 2011

Vaccine News and Research

Latest Vaccine News and Research

Immediate action needed to curb spread of TB, especially among children

HIV vaccine research showing promise

Rush Foundation, Copenhagen Consensus Center examine how to spend hypothetical AIDS funding

Researchers modify HIV in a way that makes it no longer able to suppress immune system

University of Zurich receives AICR grant to improve vaccines against Burkitt's lymphoma

MSU creates new malaria vaccine with immune-stimulating gene

Roundup: Patient dies after medical error during Calif. nurses strike; grocery workers ratify contract that had partially hinged on health care

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

Afinitor Phase III study on angiomyolipomas associated with TSC meets primary endpoint

Combination of Afinitor, exemestane reduces risk of breast cancer progression in women

Fact check: Health care claims in Republican debate

Britain’s health workers urged to get flu shots to protect patients

Rotavirus vaccine saved 65,000 hospitalizations and $278 million in healthcare costs: Study

Janssen Biotech receives FDA approval for Remicade to treat UC in children

Vaccination must be part of response to cholera outbreak in Haiti

EMA CHMP adopts positive opinion for Soliris to treat atypical hemolytic uremic syndrome

Is enough being done to fight child mortality?

Bachmann, Perry wrestle over HPV issue

First Edition: September 23, 2011

Study identifies genetic mutations that affect immune response to measles vaccination

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in